Company: PTPI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001410578-25-001349
Chunk: 5

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 1L
Chunk 5
---
 the date of this filing, management has substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset amounts or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

The Company will need to raise additional capital to finance its losses and negative cash flows from operations and may continue to be dependent on additional capital raising as long as our products do not reach commercial profitability. There are no assurances that the Company would be able to raise additional capital on terms favorable to it. If the Company is unsuccessful in commercializing its products and raising capital, it will need to reduce activities, curtail or cease operations.

​